Jan 31, 2025 · Library of Congress
Introduced in House
H.R. 890 · House · Introduced Jan 31, 2025
Sponsored by Patrick Ryan (D, NY-18)
- INTRODUCED
- COMMITTEEJan 31, 2025
- PASSED HOUSE
- SENATE
- LAW
In committee. Latest action on Jan 31, 2025: Referred to the House Committee on the Judiciary. It has 0 cosponsors and 3 recorded actions, and 3 organizations cited it in Q2 2026 lobbying disclosures.
Recent actions
3 totalJan 31, 2025 · Library of Congress
Introduced in House
Jan 31, 2025 · House floor actions
Referred to the House Committee on the Judiciary.
Reported lobbying
3
organizations cited H.R. 890 in a lobbying disclosure
Q2 2026 · the most recent completed reporting period you can see
| Organization | Filed by | Total Q2 2026 lobbying |
|---|---|---|
| Pharmaceutical Research and Manufacturers of America (PhRMA) | In-house | $7,360,000 |
| Glaxosmithkline | In-house | $890,000 |
| American Intellectual Property Law Association | In-house | $10,000 |
These totals are not spending on this bill. Lobbying is reported per filing, not per issue — each figure is everything the organization reported for the period, across every bill and agency it named. Read it as scale of presence.
Latest activity
July 2026
Lobbying reported · Pharmaceutical Research and Manufacturers of America (PhRMA) · Jul 20
Pharmaceutical Research and Manufacturers of America (PhRMA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $7,360,000
BillsH.Con.Res. 14H.R. 1H.R. 4H.R. 890H.R. 946H.R. 1262H.R. 1492H.R. 2214H.R. 3152H.R. 3160H.R. 3269H.R. 3521H.R. 4121H.R. 4317H.R. 4570H.R. 4780H.R. 5256H.R. 5304H.R. 5342H.R. 5371H.R. 6089H.R. 6423H.R. 6485H.R. 6610H.R. 6624H.R. 6938H.R. 7148H.R. 7837H.R. 7953H.R. 8269H.R. 8646H.R. 8800H.R. 8845H.R. 9102H.R. 9142H.R. 9260H.R. 9310H.R. 9661H.Res. 566S. 2S. 43S. 355S. 652S. 832S. 864S. 1040S. 1041S. 1071S. 1095S. 1096S. 1097S. 1387S. 1414S. 1546S. 1553S. 1954S. 2256S. 2276S. 2296S. 2354S. 2587S. 2620S. 2658S. 3014S. 3345S. 3452S. 3788S. 4784
Lobbying reported · Glaxosmithkline · Jul 16
Glaxosmithkline reported 2nd Quarter (Apr 1 - June 30) lobbying for Glaxosmithkline — $890,000
BillsH.Con.Res. 14H.R. 1H.R. 4H.R. 890H.R. 946H.R. 1262H.R. 1492H.R. 2214H.R. 3152H.R. 3160H.R. 3269H.R. 3521H.R. 4121H.R. 4317H.R. 4570H.R. 4780H.R. 5256H.R. 5304H.R. 5342H.R. 5509H.R. 6423H.R. 6485H.R. 6610H.R. 6624H.R. 6938H.R. 7148H.R. 7391H.R. 7837H.R. 7953H.R. 8269H.R. 8646H.R. 8800H.R. 8845H.R. 9102H.R. 9142H.R. 9260H.R. 9310H.Res. 566S. 2S. 43S. 355S. 652S. 832S. 864S. 891S. 1040S. 1041S. 1071S. 1095S. 1096S. 1097S. 1414S. 1546S. 1553S. 1954S. 2256S. 2276S. 2296S. 2354S. 2587S. 2620S. 2658S. 3014S. 3345S. 3452S. 3788S. 4784
You’re all caught up.